Global PEGylated Proteins Market Study 2015-2025, by Segment (Colony Stimulating Factors, Interferons, Erythropoietin (EPO)), by Market (Cancer Treatment, HepatitisChronic Kidney Disease, Chronic Kidney Disease), by Company (Merck Sharp & Dohme, ENZON Pharmaceuticals, Roche)

October 2018 | 66 pages | ID: G3770675439EN
99Strategy

Abstracts

Snapshot

The global PEGylated Proteins market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Colony Stimulating Factors
• Interferons
• Erythropoietin (EPO)
• Recombinant Factor Viii
• Monoclonal Antibodies
• Others

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Cancer Treatment
• Hepatitis
• Chronic Kidney Disease
• Leukemia
• SCID
• Rheumatoid Arthritis & Crohn's Disease
• Others

Company Coverage (Sales data, Main Products & Services etc.):

• Merck Sharp & Dohme
• ENZON Pharmaceuticals
• Roche
• Pfizer
• Amgen
• UCB
• Crealta (Savient)

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 PEGylated Proteins Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 PEGYLATED PROTEINS MARKET BY TYPE

2.1 By Type
  2.1.1 Colony Stimulating Factors
  2.1.2 Interferons
  2.1.3 Erythropoietin (EPO)
  2.1.4 Recombinant Factor Viii
  2.1.5 Monoclonal Antibodies
  2.1.6 Others
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Cancer Treatment
  3.1.2 Hepatitis
  3.1.3 Chronic Kidney Disease
  3.1.4 Leukemia
  3.1.5 SCID
  3.1.6 Rheumatoid Arthritis & Crohn's Disease
  3.1.7 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Merck Sharp & Dohme (Company Profile, Sales Data etc.)
5.2 ENZON Pharmaceuticals (Company Profile, Sales Data etc.)
5.3 Roche (Company Profile, Sales Data etc.)
5.4 Pfizer (Company Profile, Sales Data etc.)
5.5 Amgen (Company Profile, Sales Data etc.)
5.6 UCB (Company Profile, Sales Data etc.)
5.7 Crealta (Savient) (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

TABLE GLOBAL PEGYLATED PROTEINS MARKET 2015-2018, BY TYPE, IN USD MILLION

Table Global PEGylated Proteins Market 2015-2018, by Type, in Volume
Table Global PEGylated Proteins Market Forecast 2019-2025, by Type, in USD Million
Table Global PEGylated Proteins Market Forecast 2019-2025, by Type, in Volume
Table Merck Sharp & Dohme Overview List
Table PEGylated Proteins Business Operation of Merck Sharp & Dohme (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ENZON Pharmaceuticals Overview List
Table PEGylated Proteins Business Operation of ENZON Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table PEGylated Proteins Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table PEGylated Proteins Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table PEGylated Proteins Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table UCB Overview List
Table PEGylated Proteins Business Operation of UCB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Crealta (Savient) Overview List
Table PEGylated Proteins Business Operation of Crealta (Savient) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global PEGylated Proteins Market Growth 2015-2018, by Type, in USD Million
Figure Global PEGylated Proteins Market Growth 2015-2018, by Type, in Volume